SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056658
Filing Date
2021-11-12
Accepted
2021-11-12 14:21:08
Documents
89
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q emma-10q_20210930.htm   iXBRL 10-Q 3248842
2 EX-31.1 emma-ex311_8.htm EX-31.1 9936
3 EX-31.2 emma-ex312_7.htm EX-31.2 10006
4 EX-32.1 emma-ex321_9.htm EX-32.1 7812
  Complete submission text file 0001564590-21-056658.txt   15317695

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA emma-20210930.xsd EX-101.SCH 83337
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20210930_cal.xml EX-101.CAL 76636
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20210930_def.xml EX-101.DEF 349772
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20210930_lab.xml EX-101.LAB 580547
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20210930_pre.xml EX-101.PRE 540494
10 EXTRACTED XBRL INSTANCE DOCUMENT emma-10q_20210930_htm.xml XML 3976442
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 211402587
SIC: 2834 Pharmaceutical Preparations